These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16430944)

  • 1. Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13.
    Kostousov V; Fehr J; Bombeli T
    Thromb Res; 2006; 118(6):723-31. PubMed ID: 16430944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13).
    Böhm M; Vigh T; Scharrer I
    Ann Hematol; 2002 Aug; 81(8):430-5. PubMed ID: 12223999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura.
    Lämmle B; Kremer Hovinga JA; Alberio L
    J Thromb Haemost; 2005 Aug; 3(8):1663-75. PubMed ID: 16102032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura.
    Rick ME; Austin H; Leitman SF; Krizek DM; Aronson DL
    Am J Hematol; 2004 Feb; 75(2):96-100. PubMed ID: 14755376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
    Lattuada A; Rossi E; Calzarossa C; Candolfi R; Mannucci PM
    Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM; Lian EC
    N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods.
    Studt JD; Böhm M; Budde U; Girma JP; Varadi K; Lämmle B
    J Thromb Haemost; 2003 Sep; 1(9):1882-7. PubMed ID: 12941027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.
    Mancini I; Valsecchi C; Lotta LA; Deforche L; Pontiggia S; Bajetta M; Palla R; Vanhoorelbeke K; Peyvandi F
    Thromb Haemost; 2014 Aug; 112(2):297-303. PubMed ID: 24740645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
    Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
    Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodologies and clinical utility of ADAMTS-13 activity testing.
    Just S
    Semin Thromb Hemost; 2010 Feb; 36(1):82-90. PubMed ID: 20391299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura].
    Hulstein JJ; Rison CN; Kappers-Klunne MC; Hene RJ; Franx A; de Groot PG; Brand A; Fijnheer R
    Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1972-6. PubMed ID: 15524133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Moake JL
    Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance].
    Korczowski B
    Med Wieku Rozwoj; 2005; 9(4):753-61. PubMed ID: 16733283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.